A new report by Canada’s Competition Bureau recommends opening more of the country’s domestic airline market to foreign companies to help lower fares.
Category: Regulation and Deregulation of Industry
-
Insurers Pledge to Ease Controversial Prior Approvals for Medical Care
Major companies had faced mounting pressure to stop denying or stalling authorization of coverage for treatments and prescriptions.
-
Airlines Challenge Protections For Travelers With Wheelchairs
A landmark rule to expand the rights of disabled air travelers has been hamstrung by a lawsuit from major airlines and delayed enforcement by the Transportation Department.
-
Chinese Companies Set Their Sights on Brazil
Confronted with tariffs and scrutiny in the United States and Europe, Chinese consumer brands are betting that they can become household names in Latin America’s biggest economy.
-
Fed’s Interest-Rate Approach Keeps It on Collision Course With Trump
The central bank signals little urgency to cut interest rates despite demands from President Trump for lower borrowing costs.
-
Tesla’s Robotaxi, Long Promised by Elon Musk, Joins a Crowded Field
Mr. Musk says the driverless taxis could begin ferrying passengers on Sunday in Austin, Texas, where other companies already have similar cars on the road.
-
Fed’s ‘Wait and See’ Approach Is Intact as New Risks Cloud Economic Outlook
The central bank is set to hold interest rates steady for its fourth straight meeting, a pause that could be extended through the summer.
-
Trumps Promote American Bitcoin, a New Crypto Mining Venture
The debut of American Bitcoin, a mining firm backed by Eric Trump and Donald Trump Jr., has heightened the ethical concerns swirling around the Trump presidency.
-
Texas OK’s $50 Million for Ibogaine Research
The state’s governor signed legislation to allow clinical trials of a psychedelic drug that shows promise for veterans in treating addiction and post-traumatic stress disorder.
-
F.D.A. Looks to A.I. to Enhance Efficiency
With a Trump-driven reduction of nearly 2,000 employees, agency officials view artificial intelligence as a way to speed drugs to the market.